Business, Policy & Funding Breaking news on Genetics & Genomics business, policy & funding. In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health A federal judge denied four motions by Guardant but turned down four others by the company. Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine The companies aim to identify therapeutic targets for Niemann-Pick disease type C, a rare genetic lysosomal storage disorder. Twist Bioscience Sees Demand for New Enzymatic DNA Synthesis Method; Stays Mum on Timeline, Details Premium The South San Francisco-based company claims the new technique is plug-and-play, low cost, scarless, and scalable but said it needs more engineering. Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Project Beacon COVID-19 was started by F-Prime Capital, GV, and the Broad Institute to help implement COVID-19 testing in Massachusetts and its environs. Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay The diagnostics and research services firm will help Mainz recruit research partners for a study assessing new biomarker additions to its CRC early detection test. Jan 13, 2022 XPhyto, TechUnit Sign Agreement to Distribute COVID-19 Test in Czech Republic Jan 13, 2022 Eagle Genomics, Quadram Institute Form Microbiome Data Research Alliance Jan 13, 2022 Interpace Commences $30M Rights Offering Jan 12, 2022 Calibre Scientific Acquires Sequencing Sample Prep Reagent Firm BrightBox Quantitation Jan 12, 2022 Coral Genomics, Crohn's & Colitis Foundation Partner on Study of IBD Treatment Response Jan 12, 2022 Invitae Launches Ciitizen Genome Information Management Platform at JPM Jan 12, 2022 JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More Jan 12, 2022 Bionano Genomics Expecting Sharp Increases in Q4, Full-Year 2021 Revenues Jan 11, 2022 Seqster, National Pancreas Foundation Partner on Pancreatic Disease Registry Jan 11, 2022 FDA Grants Emergency Use Authorization for Premier Medical COVID-19 Test Jan 11, 2022 JPM Healthcare Conference Day 1: Seer, Twist, 10x, Guardant, Natera, Bruker, Adaptive, Qiagen, Sema4 Jan 11, 2022 Freenome Nets $290M Investment From Roche Jan 11, 2022 SQI to Acquire Precision Biomonitoring SARS-CoV-2 Testing Business, Technology Jan 11, 2022 Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results Jan 11, 2022 Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference Jan 11, 2022 NeoGenomics Blood-Based Minimal Residual Disease Test Receives CE Mark Jan 10, 2022 Top Five Articles on GenomeWeb Last Week: Illumina, SomaLogic, OraSure, and More Jan 10, 2022 Singular Genomics Teams up With Five Companies to Integrate G4 Sequencer With Existing NGS Products Jan 10, 2022 Thermo Fisher Signs $5B Loan Agreement Jan 10, 2022 23andMe Gains FDA Clearance for Direct-to-Consumer Prostate Cancer Genetic Risk Test Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan And a Fourth? A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times. For Better Science Software A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports. Recommendation Explanations The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information. Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.